Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Analysis of genome maintenance in Philadelphia-positive leukemia following HDAC inhibition and doxorubicin treatment

ABSTRACT: Analysis of genome maintenance in Philadelphia-positive leukemia following HDAC inhibition and doxorubicin treatment

PROVIDER: PRJNA342491 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR4228370.fastq.gz	Fastqsanger.gz
	SRR4228380.fastq.gz	Fastqsanger.gz
	SRR4228371.fastq.gz	Fastqsanger.gz
	SRR4228381.fastq.gz	Fastqsanger.gz
	SRR4228372.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 43

Similar Datasets

Genome-wide nuclesome occupancy following HDAC inhbitor and/or doxorubicin treatment

Project description:The goal of this study is to identify nucleosome occupancies in leukemic cells treated with either HDAC inhibitor or doxorubicin or HDAC inhibitor plus doxorubicin

2021-07-01 | GSE86784 | GEO

Analysis of genome maintenance in Philadelphia-positive leukemia following HDAC inhibition and doxorubicin treatment

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-07-01 | GSE86785 | GEO

Next Generation Sequencing of RNA from HDAC inhibitor and/or doxorubicin treated samples

Project description:Our study represents the first detailed analysis of transcriptomes in HDAC inhibitor and doxorubicin treated leukemic cells. The goal of this study is to identify gene expression patterns in HDAC and/or doxorubicin treated leukemic cells

2021-07-01 | GSE86783 | GEO

Geothlypis philadelphia

Project description:Geothlypis philadelphia

| PRJNA959339 | ENA

Geothlypis philadelphia

Project description:Geothlypis philadelphia overview

| PRJNA1202291 | ENA

Geothlypis philadelphia

Project description:Geothlypis philadelphia (mourning warbler), bGeoPhi1

| PRJNA1201827 | ENA

Effect of imatinib on philadelphia chromosome positive acute lymphoblastic leukemia

Project description:The Philadelphia chromosome (Ph) encodes the oncogenic BCR-ABL1 tyrosine kinase, which defines a subset of acute lymphoblastic leukemia (ALL) with a particularly unfavorable prognosis. In this study, the tyrosine kinase inhibitor imatinib was used for pharmacological inhibition of BCR-ABL1. Gene expression profiles of Ph+ ALL cell lines were analyzed in response to imatinib treatment.

2010-09-10 | GSE23743 | GEO

Effect of imatinib on philadelphia chromosome positive acute lymphoblastic leukemia

2010-09-10 | E-GEOD-23743 | biostudies-arrayexpress

Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL)

Project description:Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL)

| PRJNA786930 | ENA

Geothlypis philadelphia

Project description:Geothlypis philadelphia (mourning warbler) genomic and transcriptomic data

| PRJNA1202160 | ENA